您当前的位置：
首页 >
文章列表页 >
Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials
更新时间：2023-05-16

    • Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials

    • Genes & Diseases   Vol. 10, Issue 2, (2023)
    • 作者机构：

      1. Institut Kanser Negara, Ministry of Health Malaysia, Putrajaya,Malaysia,62250

      2. First School of Clinical Medicine, Beijing University of Chinese Medicine,Beijing,China,100029

      3. Department of Oncology and Hematology, Dongzhimen Hospital, Beijing University of Chinese Medicine,Beijing,China,100700

    • DOI：10.1016/j.jtcms.2023.03.004    

      CLC：

    • Published：2023，

      Published Online：1 April 2023，

    扫 描 看 全 文

  • Jing Xu, Kang Wu, Xiao Li, et al. Effectiveness and safety of seven oral Chinese patent medicines as adjuvant therapy for cancer-related anemia: A systematic review and network meta-analysis of randomized controlled trials. [J]. Genes & Diseases 10(2).(2023) DOI： 10.1016/j.jtcms.2023.03.004.

  •  
  •  
查看原文

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

No data

Related Author

No data

Related Institution

No data
0